Established IPO11 as the nuclear import factor required to sustain β-catenin-driven Wnt transcription in APC-mutant cancer, identifying a previously unknown node controlling oncogenic Wnt signaling.
Evidence Genome-wide CRISPR screen with IPO11 knockout, nuclear fractionation/western blot for β-catenin, target gene expression, and patient-derived CRC organoid proliferation assays
- No direct biochemical demonstration that IPO11 binds β-catenin or a recognition motif
- Cargo specificity and breadth beyond β-catenin not defined
- No structural model of the IPO11–cargo interaction